2 results match your criteria: "The First Hospital Affiliated to Guangdong Pharmaceutical University[Affiliation]"
Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study.
Gastroenterol Res Pract
April 2016
Department of Gastroenterology, The First Hospital Affiliated to Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Background. Endoscopic retrograde cholangiopancreatography (ERCP) is an established treatment modality for bile duct disorders, but patients have a risk of post-ERCP pancreatitis (PEP) and biliary sepsis. Aim.
View Article and Find Full Text PDF[Amelioration of inflammatory reaction in patients with severe sepsis with inosine].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
April 2013
Department of Intensive Care Unit, the First Hospital Affiliated to Guangdong Pharmaceutical University, Guangzhou 510080, Guangdong, China.
Objective: To evaluate the therapeutic effect of inosine in patients with severe sepsis.
Methods: A prospective study was conducted. Eighty-five severe sepsis patients hospitalized in intensive care unit (ICU) from March 2011 to August 2012 were included and randomized into three groups: 25 cases as conventional therapy group, who were treated with routine treatments; 28 patients were given inosine within 6 hours besides routine treatments; 32 patients were given inosine after 6 hours together with routine treatments.